Eusol Biotech Co.,Ltd. (UNQ: 6652)
Health Care · Biotechnology · TW
NT$—
— today · — 1Y
Eusol Biotech Co.,Ltd. (UNQ: 6652) operates in the Biotechnology industry within the Health Care sector. The company is valued at $8.45M and employs 9 people.
trading between 1.87 and 10.20.
Tweenvest scores Eusol Biotech Co.,Ltd. across four factors: quality 42/100, value 43/100. Its strongest factor is value.
6652 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $8.45M
- Revenue (TTM)
- $66.14K
- P/E
- —
- EPS
- -0.30
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- NT$10.20
- 52-week low
- NT$1.87
- Avg volume (3M)
- —
- Shares outstanding
- 137.00M
- Employees
- 9
- Next earnings
- —
About Eusol Biotech Co.,Ltd.
Eusol Biotech Co.,Ltd. focuses on research and development of new biotech drugs for sleep disorders. Its pipeline includes ES135, a recombinant human acidic fibroblast growth factor (rhFGF1) for repairing neuron function; and SM-1, a 3-in-1 capsule containing 3 commercial drugs with sedative effect. The company was founded in 1994 and is headquartered in Taipei, Taiwan.
- Founded
- 1994
- Listed since
- Aug 29, 2018
- Exchange
- Unquoted Security
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $263.50 | -0.55% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $440.25 | +0.21% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $145.32 | -0.55% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.33 | +0.05% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $825.06 | -1.08% |
| argenx SEENXTBR: ARGX | $65.85B | €867.40 | -3.84% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $135.44 | -6.64% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.